JPWO2023081689A5 - - Google Patents
Info
- Publication number
- JPWO2023081689A5 JPWO2023081689A5 JP2024525233A JP2024525233A JPWO2023081689A5 JP WO2023081689 A5 JPWO2023081689 A5 JP WO2023081689A5 JP 2024525233 A JP2024525233 A JP 2024525233A JP 2024525233 A JP2024525233 A JP 2024525233A JP WO2023081689 A5 JPWO2023081689 A5 JP WO2023081689A5
- Authority
- JP
- Japan
- Prior art keywords
- polynucleotide
- nucleotides
- seq
- sequence
- inventions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163275425P | 2021-11-03 | 2021-11-03 | |
| US63/275,425 | 2021-11-03 | ||
| US202263352158P | 2022-06-14 | 2022-06-14 | |
| US63/352,158 | 2022-06-14 | ||
| PCT/US2022/079124 WO2023081689A2 (en) | 2021-11-03 | 2022-11-02 | Polynucleotides, compositions, and methods for genome editing |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024542995A JP2024542995A (ja) | 2024-11-19 |
| JPWO2023081689A5 true JPWO2023081689A5 (https=) | 2025-11-12 |
| JP2024542995A5 JP2024542995A5 (https=) | 2025-11-12 |
Family
ID=84537879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525233A Pending JP2024542995A (ja) | 2021-11-03 | 2022-11-02 | ゲノム編集のためのポリヌクレオチド、組成物、及び方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240301377A1 (https=) |
| EP (1) | EP4426822A2 (https=) |
| JP (1) | JP2024542995A (https=) |
| KR (1) | KR20240114296A (https=) |
| AU (1) | AU2022382975A1 (https=) |
| CA (1) | CA3237303A1 (https=) |
| CL (1) | CL2024001332A1 (https=) |
| CO (1) | CO2024007019A2 (https=) |
| IL (1) | IL312508A (https=) |
| MX (1) | MX2024005242A (https=) |
| TW (1) | TW202325848A (https=) |
| WO (1) | WO2023081689A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12401411B2 (en) * | 2020-05-08 | 2025-08-26 | Telefonaktiebolaget Lm Ericsson (Publ) | Versatile AAS receiver |
| WO2021228349A1 (en) | 2020-05-11 | 2021-11-18 | Telefonaktiebolaget Lm Ericsson (Publ) | Efficient prach scheduling |
| WO2025081064A2 (en) * | 2023-10-11 | 2025-04-17 | Illumina, Inc. | Thermophilic deaminase and methods for identifying modified cytosine |
| WO2025137301A1 (en) * | 2023-12-20 | 2025-06-26 | Intellia Therapeutics, Inc. | Methods for rapid engineering of cells |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5585481A (en) | 1987-09-21 | 1996-12-17 | Gen-Probe Incorporated | Linking reagents for nucleotide probes |
| US5378825A (en) | 1990-07-27 | 1995-01-03 | Isis Pharmaceuticals, Inc. | Backbone modified oligonucleotide analogs |
| KR940703846A (ko) | 1991-12-24 | 1994-12-12 | 비. 린네 파샬 | 갭(gap)이 형성된 2′ 변성된 올리고뉴클레오티드(gapped 2′ modifed oligonucleotides) |
| US6169169B1 (en) | 1994-05-19 | 2001-01-02 | Dako A/S | PNA probes for detection of Neisseria gonorrhoeae and Chlamydia trachomatis |
| WO2006007712A1 (en) | 2004-07-19 | 2006-01-26 | Protiva Biotherapeutics, Inc. | Methods comprising polyethylene glycol-lipid conjugates for delivery of therapeutic agents |
| CA2895155C (en) | 2012-12-17 | 2021-07-06 | President And Fellows Of Harvard College | Rna-guided human genome engineering |
| EP3608308B1 (en) | 2013-03-08 | 2021-07-21 | Novartis AG | Lipids and lipid compositions for the delivery of active agents |
| AU2014227653B2 (en) | 2013-03-15 | 2017-04-20 | The General Hospital Corporation | Using RNA-guided foki nucleases (RFNs) to increase specificity for RNA-guided genome editing |
| US20150165054A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting caspase-9 point mutations |
| ES2895651T3 (es) | 2013-12-19 | 2022-02-22 | Novartis Ag | Lípidos y composiciones lipídicas para la administración de agentes activos |
| EP3169309B1 (en) | 2014-07-16 | 2023-05-10 | Novartis AG | Method of encapsulating a nucleic acid in a lipid nanoparticle host |
| ES2964690T3 (es) | 2015-09-21 | 2024-04-09 | Trilink Biotechnologies Llc | Método para sintetizar ARN con caperuza 5' |
| TWI773666B (zh) | 2016-03-30 | 2022-08-11 | 美商英特利亞醫療公司 | Crispr/cas 組分之脂質奈米粒子調配物 |
| WO2018067447A1 (en) | 2016-10-03 | 2018-04-12 | Itellia Therapeutics, Inc. | Improved methods for identifying double strand break sites |
| CA3057192A1 (en) * | 2017-03-23 | 2018-09-27 | President And Fellows Of Harvard College | Nucleobase editors comprising nucleic acid programmable dna binding proteins |
| PT3688162T (pt) | 2017-09-29 | 2024-04-23 | Intellia Therapeutics Inc | Formulações |
| AR113154A1 (es) | 2017-09-29 | 2020-01-29 | Intellia Therapeutics Inc | Polinucleótidos, composiciones y métodos para edición del genoma |
| AU2018364993B2 (en) | 2017-11-10 | 2022-10-06 | University Of Massachusetts | Targeted CRISPR delivery platforms |
| EP3850088A4 (en) * | 2018-09-07 | 2023-07-19 | Beam Therapeutics, Inc. | Compositions and methods for improving base editing |
| WO2020072605A1 (en) | 2018-10-02 | 2020-04-09 | Intellia Therapeutics, Inc. | Ionizable amine lipids |
| BR112021007123A2 (pt) | 2018-10-15 | 2021-08-10 | University Of Massachusetts | edição de base de dna programável pelas proteínas de fusão nme2cas9-desaminase |
| IL314386A (en) | 2018-12-05 | 2024-09-01 | Intellia Therapeutics Inc | amine modified lipids |
| BR112021019224A2 (pt) | 2019-03-28 | 2021-11-30 | Intellia Therapeutics Inc | Polinucleotídeos, composições e métodos para expressão de polipeptídeo |
| WO2020219876A1 (en) | 2019-04-25 | 2020-10-29 | Intellia Therapeutics, Inc. | Ionizable amine lipids and lipid nanoparticles |
| AU2020293211B2 (en) * | 2019-06-11 | 2026-03-05 | Pairwise Plants Services, Inc. | Methods of producing plants with altered fruit development and plants derived therefrom |
| CN114616002A (zh) * | 2019-09-13 | 2022-06-10 | 瑞泽恩制药公司 | 使用由脂质纳米颗粒递送的crispr/cas系统在动物中进行的转录调控 |
| CR20230305A (es) * | 2020-12-11 | 2023-11-10 | Intellia Therapeutics Inc | Polinucleótidos, composiciones y métodos para la edición del genoma que implican desaminación |
-
2022
- 2022-11-02 EP EP22826533.6A patent/EP4426822A2/en active Pending
- 2022-11-02 JP JP2024525233A patent/JP2024542995A/ja active Pending
- 2022-11-02 MX MX2024005242A patent/MX2024005242A/es unknown
- 2022-11-02 TW TW111141875A patent/TW202325848A/zh unknown
- 2022-11-02 KR KR1020247018182A patent/KR20240114296A/ko active Pending
- 2022-11-02 IL IL312508A patent/IL312508A/en unknown
- 2022-11-02 CA CA3237303A patent/CA3237303A1/en active Pending
- 2022-11-02 WO PCT/US2022/079124 patent/WO2023081689A2/en not_active Ceased
- 2022-11-02 AU AU2022382975A patent/AU2022382975A1/en active Pending
-
2024
- 2024-04-30 CL CL2024001332A patent/CL2024001332A1/es unknown
- 2024-05-01 US US18/652,180 patent/US20240301377A1/en active Pending
- 2024-05-31 CO CONC2024/0007019A patent/CO2024007019A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110291198B (zh) | 经修饰的指导rna | |
| JP2025063317A5 (https=) | ||
| Haffar et al. | The matrix protein gene sequence analysis reveals close relationship between peste des petits ruminants virus (PPRV) and dolphin morbillivirus | |
| JP2021522783A5 (https=) | ||
| BR112019015244A2 (pt) | ácidos nucleicos codificando proteínas associadas a crispr e usos dos mesmos | |
| JPS60500796A (ja) | 植物細胞での発現に適したキメラ遺伝子 | |
| US12129478B1 (en) | Engineered adenosine deaminases and base editors thereof | |
| JP2002503459A5 (https=) | ||
| Jeeva et al. | Crimean-Congo hemorrhagic fever virus nucleocapsid protein augments mRNA translation | |
| JPWO2023283092A5 (https=) | ||
| KR20230007218A (ko) | 초소형 염기교정 시스템 및 이의 용도 | |
| CN119421716A (zh) | 用于环状rna亲和纯化的组合物和方法 | |
| US9809632B2 (en) | Universal protein tag for double stranded nucleic acid delivery | |
| CN112708605A (zh) | 一个Cas9蛋白拆分得到的蛋白组及其应用 | |
| JPWO2022125968A5 (https=) | ||
| JPWO2023081689A5 (https=) | ||
| JPWO2023039378A5 (https=) | ||
| IL303892A (en) | In vitro assembly of RNA-encapsulating enalavirus capsids | |
| JPS5951793A (ja) | 新規クロ−ニングビヒクル | |
| JPS6047683A (ja) | プロモ−タ− | |
| WO2025081541A1 (zh) | 非天然rna的制备方法及产品 | |
| KR20240141024A (ko) | E1347A DddAtox 변이체-TnpB fusion 단백질을 이용한 유전자 가위 시스템 | |
| TW202246510A (zh) | 以crispr/slucas9治療第1型肌強直性營養不良之組合物及方法 | |
| JPWO2022204093A5 (https=) | ||
| CN114457077A (zh) | 靶向新型冠状病毒rna及其反义链utr的脱氧核酶及其应用 |